Search Results

There are 3090 results for: content related to: IL -28 B polymorphisms and the response to antiviral therapy in HCV genotype 2 and 3 varies by ethnicity: a meta-analysis

  1. Effects of IL-28B gene polymorphism on response to peginterferon plus ribavirin combination therapy for genotype 2 chronic hepatitis C

    Hepatology Research

    Volume 43, Issue 9, September 2013, Pages: 919–924, Yu Shimoyama, Akito Nozaki, Manabu Morimoto, Satoshi Moriya, Masaaki Kondo, Hiroyuki Fukuda, Kazushi Numata, Eiji Miyajima, Mari S. Oba, Masataka Taguri, Satoshi Morita, Shin Maeda and Katsuaki Tanaka

    Version of Record online : 2 JAN 2013, DOI: 10.1111/hepr.12037

  2. Treatment efficacy of pegylated interferon plus ribavirin therapy in chronic hepatitis C patients with mixed genotype 1/2 infection

    Journal of Gastroenterology and Hepatology

    Volume 29, Issue 5, May 2014, Pages: 1012–1018, Ching-I Huang, Chung-Feng Huang, Jee-Fu Huang, Chia-Yen Dai, Ming-Lun Yeh, Ming-Yen Hsieh, Zu-Yau Lin, Shinn-Cherng Chen, Liang-Yen Wang, Ming-Lung Yu and Wan-Long Chuang

    Version of Record online : 21 APR 2014, DOI: 10.1111/jgh.12467

  3. Clinical utility of host genetic IL-28B variants in hepatitis C virus genotype 1 Asian patients retreated with pegylated interferon plus ribavirin

    Journal of Gastroenterology and Hepatology

    Volume 28, Issue 9, September 2013, Pages: 1515–1520, Chung-Feng Huang, Ming-Lun Yeh, Meng-Hsuan Hsieh, Ming-Yen Hsieh, Zu-Yau Lin, Shinn-Cherng Chen, Liang-Yen Wang, Jee-Fu Huang, Suh-Hang Hank Juo, Yi-Ching Lin, Chia-Yen Dai, Wan-Long Chuang and Ming-Lung Yu

    Version of Record online : 22 AUG 2013, DOI: 10.1111/jgh.12211

  4. You have free access to this content
    Meta-analysis: IL-28B genotype and sustained viral clearance in HCV genotype 1 patients

    Alimentary Pharmacology & Therapeutics

    Volume 36, Issue 2, July 2012, Pages: 104–114, A. S. Rangnekar and R. J. Fontana

    Version of Record online : 21 MAY 2012, DOI: 10.1111/j.1365-2036.2012.05145.x

  5. You have free access to this content
    HCV Therapeutics: Approved Agents

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 1091A–1168A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26880

  6. Multicenter prospective study to optimize the efficacy of triple therapy with telaprevir in patients with genotype 1b hepatitis C virus infection according to an algorithm based on the drug Adherence, IL-28B Gene Allele and Viral Response Trial (AG & RGT)

    Hepatology Research

    Volume 45, Issue 11, November 2015, Pages: 1091–1099, Kayoko Sugawara, Youhei Koushima, Mie Inao, Nobuaki Nakayama, Sumiko Nagoshi, Koji Yakabi, Masaya Tamano, Shinichi Asabe, Ko Nishikawa, Youji Harada, Chuichi Sekine, Yuji Fukuya, Junji Funyu, Yoshiaki Hashimoto and Satoshi Mochida

    Version of Record online : 3 MAR 2015, DOI: 10.1111/hepr.12475

  7. You have free access to this content
    Role of interleukin-28B polymorphisms in the treatment of hepatitis C virus genotype 2 infection in Asian patients

    Hepatology

    Volume 53, Issue 1, January 2011, Pages: 7–13, Ming-Lung Yu, Chung-Feng Huang, Jee-Fu Huang, Ning-Chia Chang, Jeng-Fu Yang, Zu-Yau Lin, Shinn-Cherng Chen, Ming-Yuh Hsieh, Liang-Yen Wang, Wen-Yu Chang, Yi-Ning Li, Mei-Shin Wu, Chia-Yen Dai, Suh-Hang Hank Juo and Wan-Long Chuang

    Version of Record online : 12 JAN 2011, DOI: 10.1002/hep.23976

  8. Response-guided peginterferon-alpha-2b plus ribavirin therapy for chronic hepatitis C patients with genotype 2 and high viral loads

    Hepatology Research

    Volume 42, Issue 9, September 2012, Pages: 854–863, Ken Sato, Hiroaki Hashizume, Yuichi Yamazaki, Norio Horiguchi, Satoru Kakizaki, Hitoshi Takagi, Masatomo Mori and the Gunma Liver Study Group

    Version of Record online : 4 APR 2012, DOI: 10.1111/j.1872-034X.2012.00997.x

  9. You have free access to this content
    Complementary role of vitamin D deficiency and the interleukin-28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C

    Hepatology

    Volume 53, Issue 4, April 2011, Pages: 1118–1126, Davide Bitetto, Giovanna Fattovich, Carlo Fabris, Elisa Ceriani, Edmondo Falleti, Ezio Fornasiere, Michela Pasino, Donatella Ieluzzi, Annarosa Cussigh, Sara Cmet, Mario Pirisi and Pierluigi Toniutto

    Version of Record online : 7 APR 2011, DOI: 10.1002/hep.24201

  10. Management of treatment-naïve chronic hepatitis C genotype 1 patients: a cost-effectiveness analysis of treatment options

    Journal of Viral Hepatitis

    Volume 22, Issue 2, February 2015, Pages: 175–183, P. A. Cortesi, A. Ciaccio, M. Rota, J. K. Lim, S. De Salvia, S. Okolicsanyi, M. Vinci, L. S. Belli, L. G. Mantovani and M. Strazzabosco

    Version of Record online : 10 JUL 2014, DOI: 10.1111/jvh.12278

  11. Association between an IL-28B genetic polymorphism and the efficacy of the response-guided pegylated interferon therapy in children with chronic hepatic C infection

    Hepatology Research

    Volume 43, Issue 4, April 2013, Pages: 327–338, Haruki Komatsu, Ayano Inui, Tomoyuki Tsunoda, Tsuyoshi Sogo and Tomoo Fujisawa

    Version of Record online : 13 SEP 2012, DOI: 10.1111/j.1872-034X.2012.01087.x

  12. You have free access to this content
    Poster Session 2: Hepatitis C: Approved Therapeutic Agents

    Hepatology

    Volume 60, Issue S1, October 2014, Pages: 659A–709A,

    Version of Record online : 1 OCT 2014, DOI: 10.1002/hep.27516

  13. HCV RNA decline in chronic HCV genotype 2 and 3 during standard of care treatment according to IL28B polymorphism

    Journal of Viral Hepatitis

    Volume 20, Issue 3, March 2013, Pages: 193–199, J. Stenkvist, A. Sönnerborg and O. Weiland

    Version of Record online : 20 AUG 2012, DOI: 10.1111/j.1365-2893.2012.01645.x

  14. You have free access to this content
    Vitamin A deficiency is associated with hepatitis C virus chronic infection and with unresponsiveness to interferon-based antiviral therapy

    Hepatology

    Volume 57, Issue 3, March 2013, Pages: 925–933, Davide Bitetto, Nadia Bortolotti, Edmondo Falleti, Sara Vescovo, Carlo Fabris, Giovanna Fattovich, Annarosa Cussigh, Sara Cmet, Ezio Fornasiere, Elisa Ceriani, Mario Pirisi and Pierluigi Toniutto

    Version of Record online : 7 FEB 2013, DOI: 10.1002/hep.26186

  15. You have free access to this content
    Hepatitis C virus and interferon type III (interferon-λ3/interleukin-28B and interferon-λ4): genetic basis of susceptibility to infection and response to antiviral treatment

    Clinical Microbiology and Infection

    Volume 20, Issue 12, December 2014, Pages: 1237–1245, E. Riva, C. Scagnolari, O. Turriziani and G. Antonelli

    Version of Record online : 12 DEC 2014, DOI: 10.1111/1469-0691.12797

  16. Value of interleukin-28B genetic polymorphism on retreatment outcomes of chronic hepatitis C genotype 1 relapsers by peginterferon alfa plus ribavirin

    Journal of Gastroenterology and Hepatology

    Volume 29, Issue 1, January 2014, Pages: 102–109, Ming-Yao Chen, Chen-Hua Liu, Ting-Chih Chen, Tung-Hung Su, Pei-Jer Chen, Ding-Shinn Chen, Jia-Horng Kao and Chun-Jen Liu

    Version of Record online : 19 DEC 2013, DOI: 10.1111/jgh.12329

  17. You have free access to this content
    HCV infection on-treatment viral kinetics: Do they still have a role?

    Clinical Liver Disease

    Volume 1, Issue 2, April 2012, Pages: 51–53, Jordan J. Feld

    Version of Record online : 26 APR 2012, DOI: 10.1002/cld.36

  18. You have free access to this content
    A multicenter survey of re-treatment with pegylated interferon plus ribavirin combination therapy for patients with chronic hepatitis C in Japan

    Hepatology Research

    Volume 43, Issue 1, January 2013, Pages: 35–43, Tsugiko Oze, Naoki Hiramatsu, Eiji Mita, Norio Akuta, Naoya Sakamoto, Hiroaki Nagano, Yoshito Itoh, Shuichi Kaneko, Namiki Izumi, Hideyuki Nomura, Norio Hayashi and Tetsuo Takehara

    Version of Record online : 18 JAN 2013, DOI: 10.1111/j.1872-034X.2012.01056.x

  19. You have free access to this content
    What's new in HCV genotype 2 treatment

    Liver International

    Volume 32, Issue s1, February 2012, Pages: 135–140, Alessandra Mangia and Leonardo Mottola

    Version of Record online : 29 DEC 2011, DOI: 10.1111/j.1478-3231.2011.02710.x

  20. Prediction of efficacy to pegylated interferon-α-2b plus ribavirin in patients with genotype 2 hepatitis C virus using viral response within 2 weeks

    Hepatology Research

    Volume 44, Issue 2, February 2014, Pages: 179–186, Yuki Wada, Hideyuki Tamai, Akiko Uno, Akira Kawashima, Naoki Shingaki, Yoshiyuki Mori, Kosaku Moribata, Kaori Miyata, Katsuhiko Higashi, Hisanobu Deguchi, Kazuki Ueda, Izumi Inoue, Takao Maekita, Mikitaka Iguchi, Jun Kato and Masao Ichinose

    Version of Record online : 26 MAR 2013, DOI: 10.1111/hepr.12101